Table of Content

1 Parkinson's Disease Drug Market Introduction and Overview
1.1 Parkinson's Disease Drug Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Parkinson's Disease Drug Revenue and Market Share by Manufacturer
2.2 Manufacturers Parkinson's Disease Drug Production Sites, Area Served, Product Types
2.3 Parkinson's Disease Drug Market Competitive Situation and Trends
2.3.1 Parkinson's Disease Drug Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Merck
3.1.1 Merck Company Profile
3.1.2 Parkinson's Disease Drug Product Overview
3.1.3 Merck Parkinson's Disease Drug Market Performance (2019-2024)
3.1.4 Merck Business Overview
3.2 Akorn
3.2.1 Akorn Company Profile
3.2.2 Parkinson's Disease Drug Product Overview
3.2.3 Akorn Parkinson's Disease Drug Market Performance (2019-2024)
3.2.4 Akorn Business Overview
3.3 GSK
3.3.1 GSK Company Profile
3.3.2 Parkinson's Disease Drug Product Overview
3.3.3 GSK Parkinson's Disease Drug Market Performance (2019-2024)
3.3.4 GSK Business Overview
3.4 Novartis
3.4.1 Novartis Company Profile
3.4.2 Parkinson's Disease Drug Product Overview
3.4.3 Novartis Parkinson's Disease Drug Market Performance (2019-2024)
3.4.4 Novartis Business Overview
3.5 Boehringer Ingelheim
3.5.1 Boehringer Ingelheim Company Profile
3.5.2 Parkinson's Disease Drug Product Overview
3.5.3 Boehringer Ingelheim Parkinson's Disease Drug Market Performance (2019-2024)
3.5.4 Boehringer Ingelheim Business Overview
3.6 Teva Pharmaceutical
3.6.1 Teva Pharmaceutical Company Profile
3.6.2 Parkinson's Disease Drug Product Overview
3.6.3 Teva Pharmaceutical Parkinson's Disease Drug Market Performance (2019-2024)
3.6.4 Teva Pharmaceutical Business Overview
3.7 Abbvie
3.7.1 Abbvie Company Profile
3.7.2 Parkinson's Disease Drug Product Overview
3.7.3 Abbvie Parkinson's Disease Drug Market Performance (2019-2024)
3.7.4 Abbvie Business Overview
3.8 Kyowa Hakko Kirin Pharma
3.8.1 Kyowa Hakko Kirin Pharma Company Profile
3.8.2 Parkinson's Disease Drug Product Overview
3.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Market Performance (2019-2024)
3.8.4 Kyowa Hakko Kirin Pharma Business Overview
3.9 Astellas Pharma
3.9.1 Astellas Pharma Company Profile
3.9.2 Parkinson's Disease Drug Product Overview
3.9.3 Astellas Pharma Parkinson's Disease Drug Market Performance (2019-2024)
3.9.4 Astellas Pharma Business Overview
3.10 Desitin Arzneimittel
3.10.1 Desitin Arzneimittel Company Profile
3.10.2 Parkinson's Disease Drug Product Overview
3.10.3 Desitin Arzneimittel Parkinson's Disease Drug Market Performance (2019-2024)
3.10.4 Desitin Arzneimittel Business Overview
3.11 Endo Pharmaceuticals
3.11.1 Endo Pharmaceuticals Company Profile
3.11.2 Parkinson's Disease Drug Product Overview
3.11.3 Endo Pharmaceuticals Parkinson's Disease Drug Market Performance (2019-2024)
3.11.4 Endo Pharmaceuticals Business Overview
4 Global Parkinson's Disease Drug Historical and Forecast Market Analysis by Type
4.1 Global Parkinson's Disease Drug Revenue and Market Share by Type
4.2 Global Parkinson's Disease Drug Revenue Market Forecast by Type (2024-2030)
5 Global Parkinson's Disease Drug Historical and Forecast Market Analysis by Application
5.1 Global Parkinson's Disease Drug Revenue Market Share by Application (2019-2024)
5.2 Parkinson's Disease Drug Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Parkinson's Disease Drug Market Size & Forecast (2019-2030)
6.2 Parkinson's Disease Drug Growth Trends Analysis by Regions
6.2.1 Parkinson's Disease Drug Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Parkinson's Disease Drug Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Parkinson's Disease Drug Forecasted Revenue Market Size by Regions (2024-2030)
6.2.4 North America Parkinson's Disease Drug Market Size & Forecast (2019-2030)
6.2.5 Europe Parkinson's Disease Drug Market Size & Forecast (2019-2030)
6.2.6 China Parkinson's Disease Drug Market Size & Forecast (2019-2030)
6.2.7 Japan Parkinson's Disease Drug Market Size & Forecast (2019-2030)
6.2.8 Korea Parkinson's Disease Drug Market Size & Forecast (2019-2030)
6.2.9 Southeast Asia Parkinson's Disease Drug Market Size & Forecast (2019-2030)
6.2.10 India Parkinson's Disease Drug Market Size & Forecast (2019-2030)
6.2.11 South America Parkinson's Disease Drug Market Size & Forecast (2019-2030)
6.2.12 Middle East & Africa Parkinson's Disease Drug Market Size & Forecast (2019-2030)
7 North America
7.1 North America Parkinson's Disease Drug Revenue by Players
7.2 North America Parkinson's Disease Drug Revenue by Types
7.3 North America Parkinson's Disease Drug Revenue by Applications
7.4 North America Parkinson's Disease Drug Revenue, Gross and Gross Margin (2019-2024)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Parkinson's Disease Drug Revenue by Players
8.2 Europe Parkinson's Disease Drug Revenue by Types
8.3 Europe Parkinson's Disease Drug Revenue by Applications
8.4 Europe Parkinson's Disease Drug Revenue, Gross and Gross Margin (2019-2024)
8.5 Europe PEST Analysis
9 China
9.1 China Parkinson's Disease Drug Revenue by Players
9.2 China Parkinson's Disease Drug Revenue by Types
9.3 China Parkinson's Disease Drug Revenue by Applications
9.4 China Parkinson's Disease Drug Revenue, Gross and Gross Margin (2019-2024)
9.5 China PEST Analysis
10 Japan
10.1 Japan Parkinson's Disease Drug Revenue by Players
10.2 Japan Parkinson's Disease Drug Revenue by Types
10.3 Japan Parkinson's Disease Drug Revenue by Applications
10.4 Japan Parkinson's Disease Drug Revenue, Gross and Gross Margin (2019-2024)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Parkinson's Disease Drug Revenue by Players
11.2 Korea Parkinson's Disease Drug Revenue by Types
11.3 Korea Parkinson's Disease Drug Revenue by Applications
11.4 Korea Parkinson's Disease Drug Revenue, Gross and Gross Margin (2019-2024)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Parkinson's Disease Drug Revenue by Players
12.2 Southeast Asia Parkinson's Disease Drug Revenue by Types
12.3 Southeast Asia Parkinson's Disease Drug Revenue by Applications
12.4 Southeast Asia Parkinson's Disease Drug Revenue, Gross and Gross Margin (2019-2024)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Parkinson's Disease Drug Revenue by Players
13.2 India Parkinson's Disease Drug Revenue by Types
13.3 India Parkinson's Disease Drug Revenue by Applications
13.4 India Parkinson's Disease Drug Revenue, Gross and Gross Margin (2019-2024)
13.5 India PEST Analysis
14 South America
14.1 South America Parkinson's Disease Drug Revenue by Players
14.2 South America Parkinson's Disease Drug Revenue by Types
14.3 South America Parkinson's Disease Drug Revenue by Applications
14.4 South America Parkinson's Disease Drug Revenue, Gross and Gross Margin (2019-2024)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Parkinson's Disease Drug Revenue by Players
15.2 Middle East & Africa Parkinson's Disease Drug Revenue by Types
15.3 Middle East & Africa Parkinson's Disease Drug Revenue by Applications
15.4 Middle East & Africa Parkinson's Disease Drug Revenue, Gross and Gross Margin (2019-2024)
15.5 Middle East & Africa PEST Analysis
16 Parkinson's Disease Drug Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Parkinson's Disease Drug Industrial Chain Analysis
17 Parkinson's Disease Drug Industry Dynamic Analysis
17.1 Parkinson's Disease Drug Market Trends Analysis
17.2 Parkinson's Disease Drug Market Drivers Analysis
17.3 Parkinson's Disease Drug Market Challenges Analysis
17.4 Parkinson's Disease Drug Market Restraints Analysis
18 Research Findings and Conclusion